Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • n/a - Asthma , Healthy
    Clinical Study Number 352.2087
    Study Indication Asthma ; Healthy
    Product n/a
    Generic Name n/a
    Lab Code n/a
    Clinical Phase n/a
    Study Title

    An exploratory, prospective, non-interventional study comparing biomarker signatures between patients with asthma and healthy volunteers and to investigate biomarkers associated with known phenotypes across asthma severities

    Study Document
    Trial synopsis 352.2087 english
  • n/a - Carcinoma, Non-Small-Cell Lung
    Clinical Study Number 1200.227
    Study Indication Carcinoma, Non-Small-Cell Lung
    Product n/a
    Generic Name n/a
    Lab Code n/a
    Clinical Phase IV
    Study Title

    Evaluation of the impact of nurse-led telephone follow-up on treatment compliance of patients treated for a locally advanced or metastatic nonsmall- cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation(s). The PARTAGE study.

    Study Document
    Trial synopsis 1200.227 english
  • n/a - Healthy
    Clinical Study Number 352.2041
    Study Indication Healthy
    Product n/a
    Generic Name n/a
    Lab Code n/a
    Clinical Phase I
    Study Title

    Safety and endotoxin-induced inflammatory response of a single iv bolus administration of 2 ng or 4 ng / kg body weight LPS in healthy subjects (single blind, placebo-controlled)

    Study Document
    Trial statement 352.2041 english
  • n/a - Diabetes Mellitus, Type 2
    Clinical Study Number 1218.174
    Study Indication Diabetes Mellitus, Type 2
    Product n/a
    Generic Name n/a
    Lab Code
    Clinical Phase IV
    Study Title

    Clinical characteristics, anti-hyperglycaemic treatment pattern and target attainment of type 2 diabetes mellitus patients in older population with or without albuminuria in China: A nationwide cross-sectional study

    Study Document
    Trial synopsis 1218.174 english
  • n/a - Healthy
    Clinical Study Number 0352-2100
    Study Indication Healthy
    Product n/a
    Generic Name n/a
    Lab Code
    Clinical Phase I
    Study Title

    The effect of potent inhibitors of drug transporters (verapamil, rifampin, cimetidine, probenecid) on pharmacokinetics of a transporter probe drug cocktail consisting of digoxin, furosemide, metformin and rosuvastatin (an open-label, randomised, crossover trial in three parts)

    Study Document
    Trial synopsis 0352-2100 english